Sequencing, disruption, and characterization of the Candida albicans sterol methyltransferase (ERG6) gene: Drug susceptibility studies in erg6 mutants

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 5, 1998, Pages 1160-1167

  Jensen Pergakes, K L ^a   Kennedy, M A ^a   Lees, N D ^a   Barbuch, R ^b   Koegel, C ^b   Bard, M ^a  

^a INDIANA UNIVERSITY   (United States)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BREFELDIN A; CERULENIN; CLOTRIMAZOLE; CYCLOHEXIMIDE; FLUPHENAZINE; KETOCONAZOLE; METHYLTRANSFERASE; NYSTATIN; TERBINAFINE; TRIDEMORPH;

ARTICLE; CANDIDA ALBICANS; CELL MEMBRANE PERMEABILITY; DRUG SENSITIVITY; FUNGUS MUTANT; GENE DISRUPTION; GENE LIBRARY; GENE SEQUENCE; GENETIC TRANSFORMATION; HETEROZYGOTE; HOMOZYGOSITY; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SEQUENCE HOMOLOGY; STEROL SYNTHESIS;

EID: 0031959699     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.5.1160     Document Type: Article

References (38)

1. Ausubel, F., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1995. Short protocols in molecular biology. 3rd ed. John Wiley & Sons, Inc., New York, N.Y.
2. Baloch, R. I., E. I. Mercer, T. E. Wiggins, and B. C. Baldwin. 1984. Inhibition of ergosterol biosynthesis in Saccharomyces cerevisiae and Ustilago maydis by tridemorph, fenpropiomorph, and fenpropidin. Phytochemistry 23:2219-2226.
3. Bard, M., N. D. Lees, L. A. Burrows, and F. W. Kleinhans. 1978. Differences in crystal violet dye uptake and cation-induced death among yeast sterol mutants. J. Bactcriol. 135:1146-1148.
4. Barrett-Bee, K., and G. Dixon. 1995. Ergosterol biosynthesis inhibition: a target for antifungal agents. Acta Biochim. Pol. 42:465-480.
5. Boeke, J. D., J. Truehart, G. Natsoulis, and G. R. Fink. 1987. 5-Fluoro-orotic acid as a selective agent in yeast molecular genetics. Methods Enzymol. 154:164-175.
6. Bouvier-Navé, P., T. Husselstein, T. Desprez, and P. Benveniste. 1997. Identification of cDNAs encoding sterol methyl transferases involved in the second methylation step of plant sterol biosynthesis. Eur. J. Biochem. 246: 518-529.
7. Brajtburg, J., W. G. Powderley, G. S. Kobayashi, and G. Medoff. 1990. Amphotericin B: current understanding of mechanism of action. Antimicrob. Agents Chemother. 34:183-188.
8. Clark, F. S., T. Parkinson, C. A. Hitchcock, and N. A. R. Gow. 1996. Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance. Antimicrob. Agents Chemother. 40:419-425.
9. Denning, D. W., K. Venkateswarlu, K. L. Oakley, M. J. Anderson, N. J. Manning, D. A. Stevens, D. W. Warnock, and S. L. Kelly. 1997. Itraconazole resistance in Aspergillus fumigatus. Antimicrob. Agents Chemother. 41:1364-1368.
10. Fonzi, W. A., and M. Y. Irwin. 1993. Isogenic strain construction and gene mapping in Candida albicans. Genetics 134:717-728.
11. Gaber, R. F., D. M. Copple, B. K. Kennedy, M. Vidal, and M. Bard. 1989. The yeast gene ERG6 is required for normal membrane function but is not essential for biosynthesis of the cell-cycle sparking sterol. Mol. Cell. Biol. 9:3447-3456.
12. Georgopapadakou, N. H., and T. J. Walsh. 1994. Human mycoses: drugs and targets for emerging pathogens. Science 264:371-373.
13. Goshorn, A. K., S. M. Grindle, and S. Scherer. 1992. Gene isolation by complementation in Candida albicans and applications to physical and genetic mapping. Infect. Immun. 60:876-884.
14. Hait, W. N., J. F. Gesmonde, and J. S. Lazo. 1993. Effect of anti-calmodulin drugs on the growth and sensitivity of C6 rat glioma cells to bleomycin. Anticancer Res. 14:1711-1721.
15. Hebeka, E. K., and M. Solotorovsky. 1965. Development of resistance to polyene antibiotics in Candida albicans. J. Bacteriol. 89:1533-1539.
16. Jandrositz, A., F. Turnowski, and G. Hogenaur. 1991. The gene encoding squalene epoxidase from Saccharomyces cerevisiae: cloning and characterization. Gene 107:155-160.
17. Kalb, V. F., J. C. Loper, C. R. Dey, C. W. Woods, and T. R. Sutter. 1986. Isolation of a cytochrome P-450 gene from Saccharomyces cerevisiae. Gene 45:237-245.
18. Kleinhans, F. W., N. D. Lees, M. Bard, R. A. Haak, and R. A. Woods. 1979. ESR determination of membrane permeability in a yeast sterol mutant. Chem. Phys. Lipids 23:143-154.
19. Lamb, D. C., B. C. Baldwin, K. J. Kwon-Chung, and S. L. Kelly. 1997. Stereoselective interaction of the azole antifungal agent SCH39304 with the cytochrome P-450 monooxygenase system isolated from Cryptococcus neoformans. Antimicrob. Agents Chemother. 41:1465-1467.
20. Lees, N. D., M. Bard, M. D. Kemple, R. A. Haak, and F. W. Kleinhans. 1979. ESR determination of membrane order parameter in yeast sterol mutants. Biochim. Biophys. Acta 553:469-475.
21. Lees, N. D., S. L. Lofton, R. A. Woods, and M. Bard. 1980. The effects of varied energy source and detergent on the growth of sterol mutants of Saccharomyces cerevisiae. J. Gen. Microbiol. 118:209-214.
22. Marcireaux, D., D. Guyonnet, and F. Karst. 1992. Construction and growth properties of a yeast strain defective in sterol 14-reductase. Curr. Genet. 22:267-272.
23. Molzhan, S. W., and R. A. Woods. 1972. Polyene resistance and the isolation of sterol mutants in Saccharomyces cerevisiae. J. Gen. Microbiol. 72:339-348.
24. Moran, G. P., D. J. Sullivan, M. C. Henman, C. E. McCreary, B. J. Harrington, D. B. Shanley, and D. C. Coleman. 1997. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob. Agents Chemother. 41:617-623.
25. Morisaki, N., H. Funabashi, R. Shimazawa, J. Furukawa, A. Kawaguchi, S. Okuda, and S. Iwasaki. 1993. Effect of side-chain structure on inhibition of yeast fatty-acid synthase by cerulenin analogues. Eur. J. Biochem. 211:111-115.
26. Parkinson, T., D. J. Falconer, and C. A. Hitchcock. 1995. Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata. Antimicrob. Agents Chemother. 39:1696-1699.
27. Pinto, W. J., and W. D. Nes. 1983. Stereochemical specificity for sterols in Saccharomyces cerevisiae. J. Biol. Chem. 258:4472-1476.
28. Powderley, W. G., G. S. Kobayashi, G. P. Herzig, and G. Medoff. 1988. Amphotericin B-resistant yeast infection in severely immunocompromised patients. Am. J. Med. 84:826-832.
29. Rine, J., W. Hansen, E. Hardeman, and R. W. Davis. 1983. Targeted selection of recombinant clones through gene dosage effects. Proc. Natl. Acad. Sci. USA 80:6750-6754.
30. Sanglard, D., F. Ischer, M. Monod, and J. Bille. 1996. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob. Agents Chemother. 40:2300-2305.
31. Sanglard, D., K. Kuchler, F. Ischer, J. L. Pagani, M. Monod, and J. Bille. 1995. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39:2378-2386.
32. Vanden Bossche, H., G. Willemsens, and P. Marichal. 1987. Anti-Candida drugs - the biochemical basis for their activity. Crit. Rev. Microbiol. 15:57-72.
33. Venkateswarlu, K., M. Taylor, N. J. Manning, M. G. Rinaldi, and S. L. Kelly. 1997. Fluconazole tolerance in clinical isolates of Cryptococcus neoformans. Antimicrob. Agents Chemother. 41:748-751.
34. Vogel, J. P., J. N. Lee, D. R. Kirsch, M. D. Rose, and E. S. Sztul. 1993. Brefeldin A causes a defect in secretion in Saccharomyces cerevisiae. J. Biol. Chem. 268:3040-3043.
35. Welihinda, A. A., A. D. Beavis, and R. J. Trumbly. 1994. Mutations in LIS1 (ERG6) gene confer increased sodium and lithium uptake in Saccharomyces cerevisiae. Biochim. Biophys. Acta 1193:107-117.
36. Wheat, J., P. Marichal, H. Vanden Bossche, A. Le Monte, and P. Connolly. 1997. Hypothesis on the mechanism of resistance to fluconazole in Histoplasma capsulatum. Antimicrob. Agents Chemother. 41:410-414.
37. White, T. 1997. Increased mRNA levels of ERG16. CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 41:1482-1487.
38. White, T. 1997. The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14α demethylase in Candida albicans. Antimicrob. Agents Chemother. 41:1488-1494.